Translate

Monday, March 25, 2019

thumbnail

MYOK MyoKardia, Inc. gains 24% Mar 25, 2019

Clinical-stage biotech developing therapies for heritable cardiomyopathies.http://www.priceseries.com/trade/MYOK-MyoKardia-Inc-stock-gains-24-percent-a-Trade-Record-by-priceSeries-2019021420190325.html

Subscribe by Email

Follow Updates Articles from This Blog via Email

No Comments

TradeVisor Product Review

Review I II III IV

Blog Archive